Daniel Grosslight
Stock Analyst at Citigroup
(0)
# 4073
Out of 5,291 analysts
130
Total ratings
30.61%
Success rate
-7.47%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Hims & Hers Health | Reiterates: Sell | 27 27 | 29.1 | -7.22% | 9 | Mar 6, 2025 | |
Cardinal Health | Maintains: Neutral | 120 129 | 136.43 | -5.45% | 5 | Jan 10, 2025 | |
Evolent Health | Maintains: Buy | 21 18 | 9.59 | 87.7% | 4 | Jan 10, 2025 | |
GoodRx Holdings | Maintains: Buy | 7 7 | 4.5 | 38.89% | 7 | Jan 10, 2025 | |
Health Catalyst | Maintains: Buy | 11 10 | 4.58 | 118.34% | 8 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 713 677 | 668.25 | 1.31% | 7 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 13 | n/a | n/a | 9 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 31 35 | 26.02 | 34.51% | 6 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 2 3 | 4.48 | -49.78% | 4 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 8.59 | 115.37% | 5 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 22.57 | 10.77% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 10 | 0.6 | 1466.67% | 10 | Apr 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 | n/a | n/a | 2 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 19 | 8.12 | 133.99% | 10 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 9 10 | 6.58 | 51.98% | 7 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 8 | 9.35 | -14.44% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 185 195 | n/a | n/a | 2 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 3.4 | -63.24% | 5 | Apr 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 2 | n/a | n/a | 1 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 18 | n/a | n/a | 2 | Jul 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 125 38 | n/a | n/a | 1 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 4 | 2.64 | 32.58% | 2 | Nov 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 37 | n/a | n/a | 4 | Dec 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 125 170 | n/a | n/a | 2 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 26 | 30.47 | -14.67% | 6 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 10.63 | 22.3% | 1 | Dec 11, 2019 |